Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
During the Trading Day
| 4.83 |  -0.09 / -1.83% |
Data as of 3:59pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 4.83 |  0.00 / 0.00% |
Volume: 6.2K |
Latest MACK News | Press Releases
Today’s Trading
| Previous close | 4.92 |
| Today’s open | 4.93 |
| Day’s range | 4.71 - 5.19 |
| Volume | 663,075 |
| Average volume (3 months) | 1,381,326 |
| Market cap | $466.7M |
| Dividend yield | -- |
Data as of 3:59pm ET, 04/24/2014
Growth & Valuation
| Earnings growth (last year) | -5.32% |
| Earnings growth (this year) | +11.99% |
| Earnings growth (next 5 years) | +5.61% |
| Revenue growth (last year) | -2.32% |
| P/E ratio | NM |
| Price/Sales | 11.04 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ITCIITI Inc | +0.06 | +0.37% |
| ACRXAcelRx Pharmaceutica... | +0.15 | +1.38% |
| VNDAVanda Pharmaceutical... | -0.79 | -5.41% |
| ARRYArray Biopharma Inc | +0.29 | +7.63% |
Data as of 4:00pm ET, 04/24/2014
Financials
| Next reporting date | May 13, 2014 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $47.8M |
| Annual profit (last year) | -$130.9M |
| Net profit margin | -273.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Robert J. Mulroy |
Senior Vice President- Operations William M. McClements |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
